dipyridamole has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with end-stage chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS) are at high risk of peri-operative cardiac complications, and myocardial perfusion scintigraphy (MPS) is commonly used for risk stratification." | 1.31 | The safety of dipyridamole in patients undergoing myocardial perfusion scintigraphy prior to lung volume reduction surgery. ( Angelides, S; da Silva, I; Freeman, AP; Parker, MK; Roman, MR, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nøjgaard, C | 1 |
| Søndergaard, SB | 1 |
| Madsen, JL | 1 |
| Møller, S | 1 |
| Nielsen, SS | 1 |
| Rehling, M | 1 |
| Hesse, B | 1 |
| Mortensen, J | 1 |
| Roman, MR | 1 |
| Angelides, S | 1 |
| Freeman, AP | 1 |
| Parker, MK | 1 |
| da Silva, I | 1 |
3 other studies available for dipyridamole and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Does the administration of dipyridamole affect the ventilatory capacity of patients with chronic obstructive lung disease?].
Topics: Aged; Dipyridamole; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; | 2005 |
[Dipyridamole infusion in chronic obstructive pulmonary disease].
Topics: Dipyridamole; Forced Expiratory Volume; Humans; Pulmonary Disease, Chronic Obstructive; Radionuclide | 2005 |
The safety of dipyridamole in patients undergoing myocardial perfusion scintigraphy prior to lung volume reduction surgery.
Topics: Aged; Aged, 80 and over; Aminophylline; Bronchodilator Agents; Dipyridamole; Dyspnea; Exercise Test; | 2001 |